Ormendes

Ormendes is a Swiss biotechnology company specializing in the development, manufacturing, and distribution of high-quality probiotics and live biotherapeutic formulations. Founded in 2015 and headquartered in Jouxtens-Mézery, Switzerland, the company focuses on modulating the gut microbiome to address various health conditions, including intestinal dysbiosis, neurodegenerative diseases, and post-viral chronic fatigue. Ormendes' core technology is SLAB51, a proprietary, highly concentrated blend of eight specific live bacterial strains (including Streptococcus thermophilus, Bifidobacterium, and Lactobacillus species). The company's commercial product portfolio includes Sivomixx, Sineomixx, Athlemixx, and Agimixx, which are backed by clinical and preclinical research demonstrating efficacy in supporting gut-brain axis health and immune function.